| Leptin in human physiology and pathophysiology CS Mantzoros, F Magkos, M Brinkoetter, E Sienkiewicz, TA Dardeno, ... American Journal of Physiology-Endocrinology and Metabolism 301 (4), E567-E584, 2011 | 749 | 2011 |
| Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals HS Moon, M Dalamaga, SY Kim, SA Polyzos, OP Hamnvik, F Magkos, ... Endocrine reviews 34 (3), 377-412, 2013 | 296 | 2013 |
| Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway OPR Hamnvik, TK Choueiri, A Turchin, RR McKay, L Goyal, M Davis, ... Cancer 121 (2), 311-319, 2015 | 220 | 2015 |
| Thyroid dysfunction from antineoplastic agents OPR Hamnvik, PR Larsen, E Marqusee Journal of the National Cancer Institute 103 (21), 1572-1587, 2011 | 178 | 2011 |
| Comparison of gonadotropin-releasing hormone agonists and orchiectomy: effects of androgen-deprivation therapy M Sun, TK Choueiri, OPR Hamnvik, MA Preston, G De Velasco, W Jiang, ... JAMA oncology 2 (4), 500-507, 2016 | 134 | 2016 |
| Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma RR McKay, GE Rodriguez, X Lin, MD Kaymakcalan, OPR Hamnvik, ... Clinical Cancer Research 21 (11), 2471-2479, 2015 | 134 | 2015 |
| Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort DM Baur, J Klotsche, OPR Hamnvik, C Sievers, L Pieper, HU Wittchen, ... Metabolism 60 (10), 1363-1371, 2011 | 131 | 2011 |
| Morbidity and mortality in patients with craniopharyngioma after surgery RK Crowley, OP Hamnvik, EP O’Sullivan, LA Behan, D Smith, A Agha, ... Clinical endocrinology 73 (4), 516-521, 2010 | 114 | 2010 |
| Leptin as a modulator of neuroendocrine function in humans SM Khan, OPR Hamnvik, M Brinkoetter, CS Mantzoros Yonsei medical journal 53 (4), 671, 2012 | 95 | 2012 |
| Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year … OPR Hamnvik, X Liu, M Petrou, H Gong, JP Chamberland, EH Kim, ... Metabolism 60 (7), 987-993, 2011 | 58 | 2011 |
| Bone densitometry in transgender and gender non-conforming (TGNC) individuals: 2019 ISCD official position HN Rosen, OPR Hamnvik, U Jaisamrarn, AO Malabanan, JD Safer, ... Journal of Clinical Densitometry 22 (4), 544-553, 2019 | 56 | 2019 |
| Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up … X Liu, OPR Hamnvik, JP Chamberland, M Petrou, H Gong, CA Christophi, ... Metabolism 63 (6), 773-782, 2014 | 51 | 2014 |
| Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis YMM Cheung, W Wang, B McGregor, OPR Hamnvik Cancer Immunology, Immunotherapy, 1-18, 2022 | 46 | 2022 |
| Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study X Liu, OPR Hamnvik, M Petrou, H Gong, JP Chamberland, CA Christophi, ... European journal of endocrinology 165 (5), 805-812, 2011 | 45 | 2011 |
| Balancing risk and benefit with oral hypoglycemic drugs OPR Hamnvik, GT McMahon Mount Sinai Journal of Medicine: A Journal of Translational and Personalized …, 2009 | 44 | 2009 |
| A flipped classroom in graduate medical education RA Blair, JB Caton, OPR Hamnvik The clinical teacher 17 (2), 195-199, 2020 | 42 | 2020 |
| Risk factors for new hypothyroidism during tyrosine kinase inhibitor therapy in advanced nonthyroidal cancer patients MG Lechner, CM Vyas, OPR Hamnvik, EK Alexander, PR Larsen, ... Thyroid 28 (4), 437-444, 2018 | 40 | 2018 |
| Telemedicine and inequities in health care access: the example of transgender health OPR Hamnvik, S Agarwal, CG AhnAllen, AL Goldman, SL Reisner Transgender Health 7 (2), 113-116, 2022 | 37 | 2022 |
| Hypothyroidism during tyrosine kinase inhibitor therapy is associated with longer survival in patients with advanced nonthyroidal cancers MG Lechner, CM Vyas, OPR Hamnvik, EK Alexander, PR Larsen, ... Thyroid 28 (4), 445-453, 2018 | 35 | 2018 |
| Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet X Liu, JY Huh, H Gong, JP Chamberland, MT Brinkoetter, OP Hamnvik, ... International journal of obesity 39 (10), 1548-1557, 2015 | 33 | 2015 |
Mantzoros ChristosHarvardVerified email at bidmc.harvard.edu
